Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Scientific Reports|April 2, 2026
Proof of concept for aqueous two-phase system-based extraction of cell-free DNA from plasma for liquid biopsy applicationsRafaela Meutelet, Benedikt C Buerfent, Timo Hess, et al.
Frontiers in Plant Science|December 19, 2018
Terpene Synthase Genes in Quercus robur - Gene Characterization, Expression and Resulting Terpenes Due to Cockchafer FeedingFriederike Carolin Creyaufmüller, Isabelle Chassignet, Horst Delb, et al.
Endocrine Pathology|August 20, 2025
Exploring Intratumoral Heterogeneity in Mixed Neuroendocrine-Nonneuroendocrine Neoplasms with Spatial Transcriptomics: Even More Diverse Than AnticipatedAnnika Weiß, Julia Teply-Szymanski, Maxime Schmitt, et al.
Histopathology|July 4, 2025
Stroma areactive invasion front areas (SARIFA) in 1,298 pT3/pT4 colorectal cancers: A strong prognostic parameter complementing established morphological criteriaSebastian Foersch, Nuwar Harb, Anne-Sophie Litmeyer, et al.
Pathologie (Heidelberg, Germany)|January 11, 2023
[Clinically relevant molecular pathological diagnostics in breast cancer]Fiona R Rodepeter, Julia Teply-Szymanski, Marcel Romey, et al.
Journal of Neuroendocrinology|January 21, 2024
Mesenteric fibrosis in patients with small intestinal neuroendocrine tumors is associated with enrichment of alpha-smooth muscle actin-positive fibrosis and COMP-expressing stromal cellsSebastian D Graf, Corinna U Keber, Akira Hattesohl, et al.
Cell Death & Disease|February 19, 2026
mTOR-driven autophagy suppression defines metabolic vulnerability in CDK4/6 inhibitor-resistant HR+/HER2- breast cancerLuise von Wichert, Alina Stroh, Marie Witt, et al.
Cell Communication and Signaling : CCS|March 14, 2025
Basal cell adhesion molecule (BCAM) promotes mesothelial-to-mesenchymal transition and tumor angiogenesis through paracrine signalingSuresh Sivakumar, Sonja Lieber, Raimund Dietze, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 10, 2024
Systematic Analysis of Homologous Recombination Deficiency Testing in Ovarian Cancer-Development of Recommendations for Optimal Assay PerformanceMarcel Romey, Fiona Rodepeter, Akira Hattesohl, et al.
The Journal of Molecular Diagnostics : JMD|October 3, 2022
Homologous Recombination Deficiency as an Ovarian Cancer Biomarker in a Real-World Cohort: Validation of Decentralized Genomic ProfilingCarsten Denkert, Marcel Romey, Brad Swedlund, et al.
Pageof 2